FUTRUE
Pharmaceutical ManufacturingBavaria, Germany201-500 Employees
FUTRUE is a mid-sized pharmaceutical and healthcare group based in Gräfelfing, Bavaria, with an international footprint spanning more than 20 affiliated companies. Its portfolio covers e-health, microbiome therapies, innovative pain treatments, and chemical-free medicines, and the group reports more than 90 drug approvals across its brands. Notable subsidiaries include SYNformulas and VERTANICAL, which exemplify the breadth of FUTRUE's activities within the pharmaceutical manufacturing industry. The company serves global healthcare markets, aiming to expand access to its diverse therapies and solutions. In March 2026, FUTRUE announced progress in developing a novel microelectrode array intended for placement on the brain surface to relay information to targeted brain areas, representing a concrete development within its neuroscience-focused initiatives. FUTRUE emphasizes bringing in new talent to sustain growth across its portfolio.